Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B

Seng Liem; Margo van Campenhout; Q Xie; Willem Pieter Brouwer; Heng Chi; X Qi; L Chen; F Tabak; Bettina Hansen; HLA Janssen

doi:10.1111/apt.15098

Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B

Seng Liem, Margo van Campenhout, Q Xie, Willem Pieter Brouwer, Heng Chi, X Qi, L Chen, F Tabak, Bettina Hansen, HLA Janssen

Gastroenterology & Hepatology

Research output: Contribution to journal › Article › Academic › peer-review

11 Citations (Scopus)

2 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	448-456
Number of pages	9
Journal	Alimentary Pharmacology & Therapeutics
Volume	49
Issue number	4
DOIs	https://doi.org/10.1111/apt.15098
Publication status	Published - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/apt.15098

Repub_114890_O-A.pdfFinal published version, 542 KB

http://hdl.handle.net/1765/114890

Cite this

Liem, S., van Campenhout, M., Xie, Q., Brouwer, W. P., Chi, H., Qi, X., Chen, L., Tabak, F., Hansen, B., & Janssen, HLA. (2019). Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B. Alimentary Pharmacology & Therapeutics, 49(4), 448-456. https://doi.org/10.1111/apt.15098

@article{176bbb0c1e2f41b69e1644ed6e5650c4,

title = "Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B",

author = "Seng Liem and {van Campenhout}, Margo and Q Xie and Brouwer, {Willem Pieter} and Heng Chi and X Qi and L Chen and F Tabak and Bettina Hansen and HLA Janssen",

year = "2019",

doi = "10.1111/apt.15098",

language = "Undefined/Unknown",

volume = "49",

pages = "448--456",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "4",

}

Liem, S , van Campenhout, M, Xie, Q, Brouwer, WP , Chi, H, Qi, X, Chen, L, Tabak, F, Hansen, B & Janssen, HLA 2019, 'Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B', Alimentary Pharmacology & Therapeutics, vol. 49, no. 4, pp. 448-456. https://doi.org/10.1111/apt.15098

Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B. / Liem, Seng ; van Campenhout, Margo; Xie, Q et al.

In: Alimentary Pharmacology & Therapeutics, Vol. 49, No. 4, 2019, p. 448-456.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B

AU - Liem, Seng

AU - van Campenhout, Margo

AU - Xie, Q

AU - Brouwer, Willem Pieter

AU - Chi, Heng

AU - Qi, X

AU - Chen, L

AU - Tabak, F

AU - Hansen, Bettina

AU - Janssen, HLA

PY - 2019

Y1 - 2019

U2 - 10.1111/apt.15098

DO - 10.1111/apt.15098

M3 - Article

VL - 49

SP - 448

EP - 456

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 4

ER -